Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

For The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)489-490
Number of pages2
JournalObstetrical and Gynecological Survey
Volume70
Issue number8
DOIs
StatePublished - Aug 29 2015

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

For The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2015). Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease. Obstetrical and Gynecological Survey, 70(8), 489-490. https://doi.org/10.1097/01.ogx.0000470817.99322.8e